As a GLP-1 receptor agonist, it stimulates the pancreas to produce insulin when blood sugar is high and inhibits glucose release from the liver when levels are low helping maintain stable blood sugar levels essential for managing diabetes
Additionally, obesity is associated with low HDL-C levels
For description of ARNA response to intrapelvic injection of GLP-1 (3 M in saline, Enzo Life science, Farmingdale, NY), ARNA was expressed as a percent changes from the baseline value and also normalized to maximal ARNA induced by intrapelvic injection of capsaicin (100 M in 5% ethanol and 95% saline, Sigma, Saint Louis, MO) thus expressed as a percent of ARNAmax as shown previously [24, 26, 34]
Delayed Gastric Emptying: The medications slow down the emptying of the stomach, which can contribute to a feeling of fullness and reduced appetite
Clear communication speeds diagnosis